Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
Department of Diabetes, King's College Hospital, London, UK.
Obes Rev. 2019 Nov;20(11):1597-1607. doi: 10.1111/obr.12917. Epub 2019 Jul 26.
The provocative idea that type 2 diabetes (T2D) may be a surgically treated disorder is based on accumulating evidence suggesting impressive remission rates of obesity and diabetes following bariatric surgery interventions. According to the "anti-incretin" theory, ingestion of food in the gastrointestinal (GI) tract, apart from activating the well-described incretin effect, also results in the parallel stimulation of a series of negative feedback mechanisms (anti-incretin effect). The primary goal of these regulations is to counteract the effects of incretins and other postprandial glucose-lowering adaptive mechanisms. Disruption of the equilibrium between incretins and anti-incretins could be an additional pathway leading to the development of insulin resistance and hyperglycemia. This theory provides an alternative theoretical framework to explain the mechanisms behind the optimal effects of metabolic surgery on T2D and underlines the importance of the GI tract in the homeostatic regulation of energy balance in humans. The anti-incretin concept is currently based on a limited amount of evidence and certainly requires further validation by additional studies. The aim of the present review is to discuss and critically evaluate recent evidence on the anti-incretin theory, providing an insight into current state and future perspectives.
2 型糖尿病(T2D)可能是一种可以通过手术治疗的疾病,这一颇具争议的观点是基于越来越多的证据提出的,这些证据表明减重手术干预可显著降低肥胖和糖尿病的缓解率。根据“抗肠促胰岛素”理论,除了激活已被充分描述的肠促胰岛素效应外,胃肠道(GI)腔内的食物摄入还会导致一系列负反馈机制(抗肠促胰岛素效应)的平行刺激。这些调节的主要目标是抵消肠促胰岛素和其他餐后降低血糖的适应性机制的作用。肠促胰岛素和抗肠促胰岛素之间平衡的破坏可能是导致胰岛素抵抗和高血糖发展的另一个途径。这一理论为解释代谢手术对 T2D 的最佳效果背后的机制提供了一个替代的理论框架,并强调了 GI 道在人类能量平衡的体内稳态调节中的重要性。抗肠促胰岛素的概念目前基于有限的证据,当然需要更多的研究来进一步验证。本综述的目的是讨论和批判性评估抗肠促胰岛素理论的最新证据,为当前的状态和未来的发展提供一个视角。